CORRELATION OF TUMOR SIZE WITH VISUAL STATUS AMONGST PATIENTS WITH PITUITARY ADENOMA
DOI:
https://doi.org/10.54112/pjicm.v5i02.122Keywords:
Pituitary Adenoma; Visual Field Defects; Bitemporal Hemianopia; Optic Chiasm Compression; MRI; Tumour Size; PerimetryAbstract
Background: Pituitary adenomas are benign neoplasms that can lead to substantial visual impairment due to their anatomical proximity to the optic chiasm. Visual dysfunction is often proportional to tumour size, with bitemporal hemianopia being the hallmark of chiasmal compression. Objective: To evaluate the correlation between tumour size and pre-operative visual field status in patients with pituitary adenoma. Study Design: Observational cross-sectional study. Settings: Conducted at the Punjab Institute of Neurosciences, Lahore, Pakistan. Duration of Study: 26 March 2025, 26 June 2025. Methods: A total of 60 patients aged 20–70 years with MRI-confirmed pituitary macroadenomas were enrolled. Tumor size (height) was measured in sagittal and coronal MRI scans (in mm ) using the method of Ikeda and Yoshimoto. Pre-operative visual function was evaluated using automated perimetry, with higher scores denoting greater visual impairment. Pearson correlation analysis was applied to determine the relationship between tumour size and visual field loss. Results: The mean tumour size in the coronal plane was 1.88 cm (SD = 0.686). A strong, statistically significant correlation was observed between sagittal and coronal measurements (r = 0.696, p < 0.001), confirming inter-plane consistency. The mean perimetry score was 2.00 (SD = 1.279). Bitemporal hemianopia was the most frequent visual defect (55.9%), followed by unilateral temporal with contralateral nasal hemianopia (17.6% and 14.7%, respectively), complete blindness (8.8%), and normal fields (2.9%). A significant positive correlation was found between larger coronal tumour size and worsening visual field scores (r = 0.682, p < 0.001; 95% CI: 0.482–0.821). Conclusion: Larger pituitary macroadenomas are strongly associated with greater visual field impairment pre-operatively. The predominance of bitemporal hemianopia supports classic optic chiasm compression, while the occurrence of atypical defects highlights anatomical variability. These findings reinforce the necessity for early neuroimaging and comprehensive visual assessment to facilitate prompt surgical intervention and preserve visual function.
References
Kabel A. Pituitary adenomas: insights into the recent trends. Journal of Cancer Research and Treatment 2020;8(2):21-24. https://doi.org/10.12691/jcrt-8-2-3
Gaballa S., Lindsay J., AlJaf A., Hlaing K., & Patel K.. Acute unilateral oculomotor nerve palsy as the initial presenting sign of nonfunctioning apoplectic gonadotroph adenoma. Cureus 2020. https://doi.org/10.7759/cureus.8819
Qin J., Li K., Wang X., & Bao Y.. A comparative study of functioning and non-functioning pituitary adenomas. Medicine 2021;100(14):e25306. https://doi.org/10.1097/md.0000000000025306
Ikeda H, Yoshimoto T. Visual disturbances in patients with pituitary adenoma. Acta Neurol Scand. 1995;92(2):157–60. https://doi.org/10.1111/j.1600-0404.1995.tb01031.x
Khan A., Alam J., Irfan-ud-Din M., Ahmad N., Idrees M., & Ullah W. Frequency of functional and non-functional pituitary adenomas in patients presented at Ayub Teaching Hospital, Abbottabad. Pakistan Journal of Neurological Surgery 2022;26(2):334-343. https://doi.org/10.36552/pjns.v26i2.699
Shen M., Sheng G., Yang Y., Wu C., Ma C., Li Y., et al. The distress and needs of Chinese patients with pituitary adenoma: a preliminary survey. Archives of Medical Science 2021. https://doi.org/10.5114/aoms/143886
Najafipour F., Hedayati N., Hedayati N., & Farhoudi M. Association of the severity and pattern of pituitary adenoma-related headache with the size and type of adenoma. Journal of Preventive Epidemiology 2023;9(2):e35213. https://doi.org/10.34172/jpe.2023.35213
Poudel H., Khambu B., Shrestha R., Khadka N., Jha R., & Bista P. Improvement of vision after resection of pituitary tumor. Journal of College of Medical Sciences-Nepal 2019;15(3):167-170. https://doi.org/10.3126/jcmsn.v15i3.24895
Perondi G., Mariante A., Azambuja F., Greggianin G., William W., Dias S.et al.. Untitled. Arquivos Brasileiros De Neurocirurgia Brazilian Neurosurgery 2023;42(02). https://doi.org/10.1055/s-013-57793
Azmeh A. Neuro-ophthalmology findings in pituitary disease (review of literature). 2019. https://doi.org/10.5772/intechopen.77065
Yi L., Alias A., Ghani A., & Bidin M. Endocrinological outcome of endoscopic transsphenoidal surgery for functioning and non-functioning pituitary adenoma. Malaysian Journal of Medical Sciences 2019;26(3):64-71. https://doi.org/10.21315/mjms2019.26.3.5
Abeedah A., Ismaeil A., Ahmed M., & Abaza H. Clinical and radiological outcomes of endoscopic endonasal transsphenoidal surgery for pituitary adenomas. The Egyptian Journal of Hospital Medicine 2022;89(2):6496-6501. https://doi.org/10.21608/ejhm.2022.270483
Karki M., Thapa A., & Roka Y.. Prolonged coma after pituitary macroadenoma surgery: a case report with short literature review. Nepal Medical College Journal 2019;21(3):244-248. https://doi.org/10.3126/nmcj.v21i3.26472
Ho R., Huang H., & Ho J.. The influence of pituitary adenoma size on vision and visual outcomes after transsphenoidal adenectomy: a report of 78 cases. Journal of Korean Neurosurgical Society 2015;57(1):23. https://doi.org/10.3340/jkns.2015.57.1.23
Qin J., Li K., Wang X., & Bao Y.. Comparative study of FPA and NFPA: the relationship between the clinical characteristics and visual function impairment in patients with pituitary adenoma. 2020. https://doi.org/10.21203/rs.3.rs-17215/v1
Ezzat S., Sylvia L., Couldwell W., Barr C., Dodge W., Vance M.et al.. The prevalence of pituitary adenomas. Cancer 2004;101(3):613-619. https://doi.org/10.1002/cncr.20412
Daly A., Rixhon M., Adam‐Guillermin C., Dempegioti A., Tichomirowa M., & Beckers A. High prevalence of pituitary adenomas: a cross-sectional study in the province of liège, Belgium. The Journal of Clinical Endocrinology & Metabolism 2006;91(12):4769-4775. https://doi.org/10.1210/jc.2006-1668
Barzaghi L., Medone M., Losa M., Bianchi S., Giovanelli M., & Mortini P. Prognostic factors of visual field improvement after trans-sphenoidal approach for pituitary macroadenomas: review of the literature and analysis by quantitative method. Neurosurgical Review 2011;35(3):369-379. https://doi.org/10.1007/s10143-011-0365-y
Khan A., Alam J., Irfan-ud-Din M., Ahmad N., Idrees M., & Ullah W. Frequency of functional and non-functional pituitary adenomas in patients presented at Ayub Teaching Hospital, Abbottabad. Pakistan Journal of Neurological Surgery 2022;26(2):334-343. https://doi.org/10.36552/pjns.v26i2.699
Khan N. and Ali W. Quantitative assessment of visual field recovery following transsphenoidal pituitary adenoma excision and its time course. JHRR 2024;4(2):957-962. https://doi.org/10.61919/jhrr.v4i2.981
Wang S., Lin S., Wei L., Zhao L., & Huang Y.. Analysis of operative efficacy for giant pituitary adenoma. BMC Surgery 2014;14(1). https://doi.org/10.1186/1471-2482-14-59
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 SMSK QAISRANI , S NAZAR , M CHAUDHARY, A BASHIR

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.